FINGOLIMOD HYDROCHLORIDE

FINGOLIMOD HYDROCHLORIDE was reported 5098 times

FINGOLIMOD HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OSSEOUS CRYPTOCOCCOSIS 14 0.6667
1 CONCENTRIC SCLEROSIS 6 0.4000
2 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
3 IDIOPATHIC CD4 LYMPHOCYTOPENIA 3 0.3333
4 TUMEFACTIVE MULTIPLE SCLEROSIS 34 0.2000
5 JC POLYOMAVIRUS TEST 3 0.2000
6 CD30 EXPRESSION 8 0.1778
7 CRYPTOCOCCAL MENINGOENCEPHALITIS 22 0.1679
8 EXPANDED DISABILITY STATUS SCALE 10 0.1333
9 CRYPTOCOCCAL CUTANEOUS INFECTION 21 0.1154
10 REST REGIMEN 5 0.1042
11 NEUROCRYPTOCOCCOSIS 6 0.0968
12 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 4 0.0952
13 EPILEPSIA PARTIALIS CONTINUA 4 0.0952
14 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 117 0.0938
15 ENZYME LEVEL ABNORMAL 12 0.0857
16 LYMPHOMATOID PAPULOSIS 23 0.0785
17 JANUS KINASE 2 MUTATION 7 0.0769
18 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 15 0.0725
19 ENCHONDROMATOSIS 6 0.0698
20 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 7 0.0667
21 RELAPSING-REMITTING MULTIPLE SCLEROSIS 57 0.0660
22 MALIGNANT MELANOMA STAGE 0 13 0.0622
23 JC VIRUS CSF TEST POSITIVE 3 0.0545
24 VISCERAL LEISHMANIASIS 38 0.0526
25 ANAL CYST 3 0.0517
26 CONGENITAL NEUROLOGICAL DISORDER 6 0.0513
27 CUTANEOUS B-CELL LYMPHOMA 3 0.0492
28 MOLLUSCUM CONTAGIOSUM 25 0.0463
29 EYELID CONTUSION 3 0.0448
30 ADRENAL GLAND CANCER METASTATIC 3 0.0441
31 VIRAL MYELITIS 3 0.0435
32 MENINGITIS CRYPTOCOCCAL 74 0.0423
33 HERPES SIMPLEX MENINGITIS 3 0.0423
34 CLINICALLY ISOLATED SYNDROME 4 0.0421
35 ELECTROCARDIOGRAM QT SHORTENED 12 0.0396
36 SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED 10 0.0394
37 VIRAL VASCULITIS 4 0.0374
38 RELAPSING MULTIPLE SCLEROSIS 11 0.0364
39 MONKEYPOX 10 0.0362
40 CONGENITAL CEREBRAL CYST 4 0.0357
41 LYMPHOPENIA 494 0.0349
42 CHEST WALL MASS 9 0.0346
43 CRYPTOCOCCOSIS 56 0.0343
44 PRODUCT SUBSTITUTION ERROR 4 0.0342
45 UPPER MOTOR NEURONE LESION 7 0.0318
46 MEDIASTINAL ABSCESS 4 0.0308
47 PULMONARY HISTOPLASMOSIS 3 0.0300
48 JC POLYOMAVIRUS TEST POSITIVE 35 0.0299
49 LOSS OF PROPRIOCEPTION 9 0.0280
50 PARAGANGLION NEOPLASM 4 0.0274
51 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 8 0.0273
52 VACCINATION FAILURE 45 0.0270
53 HERPES ZOSTER REACTIVATION 7 0.0267
54 HER2 POSITIVE BREAST CANCER 10 0.0267
55 PRECANCEROUS LESION OF DIGESTIVE TRACT 3 0.0265
56 FEAR-RELATED AVOIDANCE OF ACTIVITIES 4 0.0263
57 ELECTROCARDIOGRAM PR SHORTENED 5 0.0238
58 CD19 LYMPHOCYTES DECREASED 3 0.0231
59 BASOPHIL COUNT DECREASED 6 0.0227
60 TRANSIENT TACHYPNOEA OF THE NEWBORN 9 0.0227
61 CHOROIDITIS 8 0.0214
62 SCHWANNOMA 4 0.0201
63 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 100 0.0200
64 PAPILLOMA VIRAL INFECTION 33 0.0200
65 DYSMETRIA 12 0.0199
66 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 162 0.0196
67 T-CELL TYPE ACUTE LEUKAEMIA 4 0.0196
68 MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE 3 0.0195
69 PROCEDURAL PNEUMOTHORAX 3 0.0194
70 CHILLBLAINS 5 0.0192
71 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 36 0.0191
72 ESSENTIAL THROMBOCYTHAEMIA 7 0.0190
73 HERPES ZOSTER INFECTION NEUROLOGICAL 3 0.0189
74 COMBINED IMMUNODEFICIENCY 3 0.0186
75 PARAPARESIS 33 0.0185
76 ANOGENITAL WARTS 16 0.0179
77 OPHTHALMOPLEGIA 28 0.0177
78 CARCINOID CRISIS 4 0.0177
79 VARICELLA VIRUS TEST POSITIVE 3 0.0176
80 INTENTION TREMOR 10 0.0176
81 GAIT SPASTIC 6 0.0175
82 PLEOCYTOSIS 10 0.0172
83 AUTOIMMUNE HYPOTHYROIDISM 4 0.0168
84 PHAEOHYPHOMYCOSIS 8 0.0167
85 JC VIRUS INFECTION 26 0.0163
86 CEREBELLAR ISCHAEMIA 3 0.0161
87 LYMPHOCYTE COUNT ABNORMAL 18 0.0160
88 LEIOMYOSARCOMA 6 0.0156
89 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 3 0.0154
90 RETINAL ANEURYSM 3 0.0150
91 HUMAN PAPILLOMA VIRUS TEST POSITIVE 6 0.0147
92 LIMBIC ENCEPHALITIS 4 0.0145
93 PYRAMIDAL TRACT SYNDROME 6 0.0143
94 CD4 LYMPHOCYTES ABNORMAL 3 0.0143
95 HEMIHYPOAESTHESIA 5 0.0142
96 MARGINAL ZONE LYMPHOMA 3 0.0140
97 SOLAR LENTIGO 13 0.0137
98 BREAST DISCOMFORT 14 0.0136
99 HYPERLIPASAEMIA 7 0.0134
100 NEEDLE FATIGUE 6 0.0131
101 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 3 0.0130
102 BLADDER DYSFUNCTION 13 0.0126
103 MACULAR OEDEMA 69 0.0123
104 HISTOPLASMOSIS DISSEMINATED 19 0.0120
105 VULVAL CANCER 7 0.0118
106 DECREASED VIBRATORY SENSE 4 0.0118
107 EPIGLOTTIC OEDEMA 3 0.0114
108 LYMPHOCYTE COUNT DECREASED 199 0.0112
109 OVERGROWTH BACTERIAL 3 0.0112
110 HERPES ZOSTER MENINGOENCEPHALITIS 4 0.0111
111 HAEMORRHAGIC INFARCTION 6 0.0109
112 HUMORAL IMMUNE DEFECT 4 0.0108
113 DISSEMINATED CRYPTOCOCCOSIS 8 0.0106
114 HERPES SIMPLEX REACTIVATION 4 0.0105
115 NEUROMYELITIS OPTICA SPECTRUM DISORDER 14 0.0104
116 ALOPECIA UNIVERSALIS 3 0.0102
117 LARGE FOR DATES BABY 9 0.0102
118 VARICELLA ZOSTER VIRUS INFECTION 21 0.0101
119 ACROCHORDON 13 0.0098
120 FEMALE STERILISATION 5 0.0097
121 MYELITIS 15 0.0097
122 MUSCLE STRENGTH ABNORMAL 4 0.0095
123 CYSTOID MACULAR OEDEMA 18 0.0095
124 LIPOSARCOMA 3 0.0094
125 ANAL SPHINCTER ATONY 4 0.0093
126 RESPIRATORY MUSCLE WEAKNESS 3 0.0093
127 MULTIPLE SCLEROSIS RELAPSE 626 0.0091
128 PERIPHERAL NERVE LESION 3 0.0091
129 QUADRIPARESIS 15 0.0090
130 BRONCHIAL CARCINOMA 7 0.0089
131 HEPATITIS E 14 0.0089
132 MULTIPLE SCLEROSIS PSEUDO RELAPSE 3 0.0088
133 REBOUND EFFECT 100 0.0088
134 SINUSITIS FUNGAL 7 0.0087
135 PRIMARY BILIARY CHOLANGITIS 4 0.0085
136 CERVICAL DYSPLASIA 18 0.0082
137 IMMUNE THROMBOCYTOPENIA 37 0.0081
138 BRAIN STEM SYNDROME 6 0.0080
139 FOLLICULAR LYMPHOMA 7 0.0080
140 DILATED CARDIOMYOPATHY 8 0.0079
141 RETROGRADE AMNESIA 4 0.0079
142 BLOOD IMMUNOGLOBULIN A DECREASED 5 0.0077
143 ENCEPHALITIS AUTOIMMUNE 10 0.0076
144 HUMAN POLYOMAVIRUS INFECTION 4 0.0075
145 TONSIL CANCER 6 0.0075
146 PNEUMONIA CRYPTOCOCCAL 7 0.0074
147 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 6 0.0074
148 OPTIC ATROPHY 12 0.0074
149 T-LYMPHOCYTE COUNT DECREASED 5 0.0073
150 CERVIX CARCINOMA 28 0.0072
151 CENTRAL NERVOUS SYSTEM LESION 98 0.0071
152 MULTIPLE SCLEROSIS 341 0.0071
153 CD4 LYMPHOCYTES DECREASED 15 0.0070
154 DEMYELINATION 28 0.0068
155 ANTI-THYROID ANTIBODY POSITIVE 3 0.0066
156 WHITE MATTER LESION 8 0.0063
157 LUNG ADENOCARCINOMA 19 0.0063
158 SARS-COV-2 ANTIBODY TEST NEGATIVE 3 0.0063
159 INFECTION REACTIVATION 7 0.0061
160 CENTRAL NERVOUS SYSTEM INFECTION 7 0.0061
161 MONOPARESIS 11 0.0061
162 SPINAL CORD DISORDER 10 0.0061
163 PRODUCT MEASURED POTENCY ISSUE 6 0.0060
164 CENTRAL SEROUS CHORIORETINOPATHY 4 0.0059
165 GLARE 3 0.0058
166 CRANIAL NERVE DISORDER 4 0.0057
167 METASTASES TO MENINGES 13 0.0057
168 NON-SMALL CELL LUNG CANCER METASTATIC 5 0.0057
169 BICYTOPENIA 11 0.0056
170 DYSLALIA 4 0.0055
171 CLUMSINESS 15 0.0055
172 QUADRIPLEGIA 11 0.0053
173 SMALL CELL LUNG CANCER 8 0.0053
174 OPTIC NEURITIS 48 0.0053
175 INFREQUENT BOWEL MOVEMENTS 13 0.0052
176 RETINAL VEIN OCCLUSION 15 0.0052
177 PROGRESSIVE MULTIPLE SCLEROSIS 6 0.0052
178 BLADDER CATHETERISATION 5 0.0052
179 VERTIGO POSITIONAL 9 0.0051
180 NEUROENDOCRINE CARCINOMA OF THE SKIN 5 0.0051
181 LYMPHOPROLIFERATIVE DISORDER 15 0.0051
182 DACTYLITIS 5 0.0051
183 AMBLYOPIA 3 0.0051
184 B-CELL LYMPHOMA 17 0.0050
185 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 3 0.0050
186 SKIN PAPILLOMA 20 0.0050
187 ELECTROCARDIOGRAM T WAVE INVERSION 11 0.0050
188 PARESIS 11 0.0049
189 CHORIORETINOPATHY 7 0.0049
190 POLYCYTHAEMIA VERA 4 0.0049
191 BREAST NEOPLASM 5 0.0048
192 MUTISM 7 0.0048
193 RECTAL TENESMUS 6 0.0048
194 SCIATIC NERVE INJURY 4 0.0048
195 ATAXIA 57 0.0048
196 CUTANEOUS T-CELL LYMPHOMA 6 0.0048
197 MICROCEPHALY 6 0.0047
198 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 3 0.0046
199 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 5 0.0046
200 ATRIOVENTRICULAR BLOCK SECOND DEGREE 14 0.0046
201 ENDOCRINE OPHTHALMOPATHY 4 0.0046
202 HEART DISEASE CONGENITAL 16 0.0045
203 FINE MOTOR SKILL DYSFUNCTION 13 0.0045
204 ABDOMINAL NEOPLASM 4 0.0045
205 B-LYMPHOCYTE COUNT DECREASED 6 0.0044
206 OPPORTUNISTIC INFECTION 8 0.0043
207 BASAL CELL CARCINOMA 67 0.0043
208 DECREASED IMMUNE RESPONSIVENESS 42 0.0043
209 ADENOCARCINOMA OF COLON 8 0.0043
210 PROCALCITONIN INCREASED 5 0.0043
211 HEMIPARESIS 72 0.0042
212 SMEAR CERVIX ABNORMAL 6 0.0042
213 SYSTEMIC INFECTION 7 0.0042
214 ACCOMMODATION DISORDER 3 0.0041
215 GAZE PALSY 7 0.0041
216 AUTOIMMUNE HAEMOLYTIC ANAEMIA 14 0.0041
217 AMYLOIDOSIS 7 0.0041
218 INVASIVE DUCTAL BREAST CARCINOMA 11 0.0040
219 LYMPHOCYTIC INFILTRATION 4 0.0040
220 DIFFUSE LARGE B-CELL LYMPHOMA 30 0.0039
221 MELANOCYTIC NAEVUS 17 0.0039
222 NEUROGENIC BLADDER 8 0.0038
223 CLAUSTROPHOBIA 4 0.0037
224 BRADYARRHYTHMIA 6 0.0036
225 MEAN PLATELET VOLUME DECREASED 3 0.0036
226 FACIAL SPASM 4 0.0036
227 FLAT AFFECT 8 0.0035
228 PAPILLARY THYROID CANCER 6 0.0034
229 SPINAL CORD INJURY 6 0.0034
230 ALLODYNIA 4 0.0034
231 FEBRILE INFECTION 4 0.0034
232 MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0033
233 MENTAL FATIGUE 5 0.0033
234 NUCHAL RIGIDITY 3 0.0033
235 MONOCYTE COUNT DECREASED 4 0.0033
236 CEREBRAL ATROPHY 13 0.0033
237 EXTENSOR PLANTAR RESPONSE 3 0.0033
238 LYMPHOCYTOSIS 7 0.0032
239 ELECTRIC SHOCK SENSATION 9 0.0032
240 PROCTITIS 9 0.0032
241 CEREBELLAR SYNDROME 7 0.0032
242 HUMAN HERPESVIRUS 6 INFECTION 6 0.0032
243 HYPERREFLEXIA 11 0.0032
244 BAND SENSATION 4 0.0032
245 HEPATOSPLENOMEGALY 8 0.0031
246 IMMUNOSUPPRESSION 27 0.0031
247 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
248 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 6 0.0030
249 AREFLEXIA 8 0.0030
250 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
251 GLIOBLASTOMA 5 0.0029
252 CERVICAL SPINAL STENOSIS 5 0.0029
253 POSTICTAL STATE 3 0.0029
254 GAMMA-GLUTAMYLTRANSFERASE INCREASED 64 0.0029
255 MYELITIS TRANSVERSE 4 0.0028
256 MALIGNANT MELANOMA 38 0.0028
257 BREAST MASS 19 0.0028
258 PERIODONTITIS 6 0.0028
259 HYPERTONIC BLADDER 8 0.0028
260 TINEA INFECTION 3 0.0027
261 SENSORY DISTURBANCE 43 0.0027
262 ADENOCARCINOMA 6 0.0027
263 NEUROLOGICAL SYMPTOM 15 0.0026
264 LUNG NEOPLASM 11 0.0026
265 NORMAL NEWBORN 14 0.0026
266 IMMUNODEFICIENCY 38 0.0025
267 COCCIDIOIDOMYCOSIS 3 0.0025
268 NON-SMALL CELL LUNG CANCER 12 0.0025
269 PULSE ABNORMAL 6 0.0025
270 SENSORY LOSS 20 0.0025
271 MONOCYTE COUNT INCREASED 9 0.0025
272 ENCEPHALITIS VIRAL 3 0.0025
273 VENTRICULAR SEPTAL DEFECT 14 0.0024
274 SQUAMOUS CELL CARCINOMA 23 0.0024
275 MALIGNANT MELANOMA IN SITU 3 0.0024
276 MATERNAL EXPOSURE TIMING UNSPECIFIED 9 0.0024
277 URINARY TRACT INFECTION BACTERIAL 6 0.0024
278 COVID-19 PNEUMONIA 28 0.0024
279 MICTURITION URGENCY 27 0.0024
280 MATERNAL EXPOSURE BEFORE PREGNANCY 16 0.0023
281 MENOPAUSE 6 0.0023
282 TONIC CLONIC MOVEMENTS 3 0.0023
283 SINUS ARRHYTHMIA 3 0.0023
284 COORDINATION ABNORMAL 32 0.0023
285 EXTRADURAL HAEMATOMA 3 0.0023
286 CORONAVIRUS INFECTION 15 0.0023
287 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
288 CLOSTRIDIUM TEST POSITIVE 5 0.0023
289 TALIPES 7 0.0023
290 BLOOD CREATININE DECREASED 7 0.0022
291 FEELING OF BODY TEMPERATURE CHANGE 13 0.0022
292 CEREBRAL VENOUS THROMBOSIS 4 0.0022
293 SKIN DEPIGMENTATION 3 0.0022
294 URINE ABNORMALITY 10 0.0022
295 MENINGITIS VIRAL 3 0.0022
296 ADENOCARCINOMA GASTRIC 2 0.0022
297 LYMPHOCYTE COUNT INCREASED 7 0.0021
298 HEPATIC PAIN 9 0.0021
299 PRECANCEROUS SKIN LESION 3 0.0020
300 ENCEPHALITIS 14 0.0020
301 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
302 BRAIN HERNIATION 6 0.0020
303 MYELOFIBROSIS 6 0.0020
304 FACIAL PARESIS 7 0.0020
305 MUSCLE SPASTICITY 24 0.0020
306 THROMBOCYTOSIS 7 0.0019
307 PARALYSIS 27 0.0019
308 NYSTAGMUS 10 0.0019
309 TINEA PEDIS 3 0.0019
310 CHRONIC SINUSITIS 7 0.0019
311 MOTOR DYSFUNCTION 19 0.0019
312 LANGUAGE DISORDER 4 0.0018
313 DEAFNESS NEUROSENSORY 6 0.0018
314 SUSPECTED COVID-19 6 0.0018
315 ENDOMETRIAL CANCER 4 0.0018
316 HEPATIC ENZYME ABNORMAL 9 0.0018
317 SERUM SICKNESS 5 0.0018
318 NEOPLASM RECURRENCE 6 0.0018
319 BLOOD CHLORIDE INCREASED 3 0.0017
320 HAEMANGIOMA 4 0.0017
321 NEUROLOGICAL DECOMPENSATION 4 0.0017
322 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
323 RESPIRATORY RATE INCREASED 15 0.0017
324 SQUAMOUS CELL CARCINOMA OF SKIN 10 0.0017
325 GUILLAIN-BARRE SYNDROME 8 0.0017
326 SKIN CANCER 35 0.0016
327 LIGAMENT SPRAIN 16 0.0016
328 APHASIA 48 0.0016
329 MYELOPATHY 3 0.0016
330 ENDOCARDITIS 8 0.0016
331 DISSEMINATED TUBERCULOSIS 4 0.0016
332 ADJUSTMENT DISORDER 2 0.0015
333 URINE OUTPUT INCREASED 4 0.0015
334 PYELONEPHRITIS ACUTE 3 0.0015
335 CATATONIA 8 0.0015
336 TRIGEMINAL NEURALGIA 6 0.0015
337 SKIN ABRASION 7 0.0015
338 CLONUS 4 0.0015
339 SKIN LESION 40 0.0015
340 RED BLOOD CELL COUNT INCREASED 4 0.0014
341 PAPULE 10 0.0014
342 MUSCLE FATIGUE 6 0.0014
343 VISUAL FIELD DEFECT 10 0.0014
344 MONOPLEGIA 6 0.0014
345 ABORTION 4 0.0014
346 URINE ANALYSIS ABNORMAL 4 0.0013
347 DYSAESTHESIA 4 0.0013
348 ECTOPIC PREGNANCY 4 0.0013
349 LEUKOPENIA 65 0.0013
350 DISEASE RECURRENCE 61 0.0013
351 VITILIGO 3 0.0013
352 PYELONEPHRITIS 11 0.0013
353 METASTASIS 9 0.0013
354 URINARY HESITATION 3 0.0013
355 INTRACRANIAL PRESSURE INCREASED 7 0.0013
356 VARICELLA 3 0.0013
357 HYPERBILIRUBINAEMIA 13 0.0013
358 PANIC REACTION 9 0.0012
359 STATUS EPILEPTICUS 14 0.0012
360 LYMPHOMA 19 0.0012
361 GASTROINTESTINAL CARCINOMA 11 0.0012
362 OTITIS MEDIA 4 0.0012
363 OVARIAN CANCER 11 0.0012
364 PLANTAR FASCIITIS 4 0.0012
365 UROSEPSIS 11 0.0012
366 PATHOLOGICAL FRACTURE 6 0.0012
367 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
368 FACIAL PARALYSIS 10 0.0012
369 NEUTROPHIL COUNT INCREASED 12 0.0012
370 REGURGITATION 4 0.0012
371 POLYMENORRHOEA 4 0.0012
372 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
373 PARTIAL SEIZURES 6 0.0011
374 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
375 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
376 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
377 MACULOPATHY 4 0.0011
378 ABDOMINAL MASS 3 0.0011
379 IRON DEFICIENCY 5 0.0011
380 BLADDER DISORDER 11 0.0011
381 CUTANEOUS VASCULITIS 4 0.0011
382 HERPES SIMPLEX 7 0.0011
383 HYPOAESTHESIA 161 0.0011
384 LEUKOENCEPHALOPATHY 4 0.0011
385 DIARRHOEA HAEMORRHAGIC 10 0.0011
386 HYPOGAMMAGLOBULINAEMIA 7 0.0011
387 PROTEIN TOTAL DECREASED 4 0.0011
388 AUTOIMMUNE THYROIDITIS 4 0.0011
389 VITAMIN B12 DECREASED 3 0.0010
390 INCONTINENCE 11 0.0010
391 CYSTITIS 33 0.0010
392 VASCULITIS 12 0.0010
393 EYE MOVEMENT DISORDER 7 0.0010
394 STRABISMUS 3 0.0010
395 TORSADE DE POINTES 8 0.0010
396 PURPURA 9 0.0010
397 SKIN ODOUR ABNORMAL 4 0.0010
398 LYMPHOEDEMA 7 0.0010
399 LOW BIRTH WEIGHT BABY 8 0.0010
400 COGNITIVE DISORDER 47 0.0010
401 DIPLOPIA 26 0.0010
402 INTRACRANIAL ANEURYSM 4 0.0010
403 ERYSIPELAS 5 0.0010
404 COVID-19 174 0.0010
405 MUSCLE TIGHTNESS 16 0.0010
406 DYSARTHRIA 37 0.0010
407 PRODUCT SUPPLY ISSUE 7 0.0010
408 PERIPHERAL ISCHAEMIA 4 0.0010
409 ALANINE AMINOTRANSFERASE INCREASED 60 0.0010
410 RECTAL CANCER 3 0.0010
411 PIGMENTATION DISORDER 6 0.0010
412 TEMPERATURE INTOLERANCE 10 0.0010
413 PERSONALITY CHANGE 9 0.0010
414 OLIGURIA 6 0.0010
415 ATRIAL SEPTAL DEFECT 8 0.0010
416 HERPES ZOSTER 54 0.0009
417 PULMONARY TUBERCULOSIS 4 0.0009
418 PURULENT DISCHARGE 4 0.0009
419 COMPRESSION FRACTURE 5 0.0009
420 SINUS BRADYCARDIA 9 0.0009
421 BALANCE DISORDER 80 0.0009
422 BLOOD TEST ABNORMAL 13 0.0009
423 BRADYCARDIA 49 0.0009
424 ASPERGILLUS INFECTION 6 0.0009
425 ORAL CANDIDIASIS 12 0.0009
426 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 3 0.0009
427 APHTHOUS ULCER 7 0.0009
428 DYSURIA 33 0.0009
429 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
430 OSTEOMYELITIS 16 0.0009
431 PNEUMONIA ASPIRATION 22 0.0009
432 PERONEAL NERVE PALSY 5 0.0009
433 URINARY RETENTION 29 0.0009
434 GAIT DISTURBANCE 166 0.0009
435 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
436 MICTURITION DISORDER 3 0.0009
437 ARTHRITIS INFECTIVE 4 0.0009
438 EXPOSURE DURING PREGNANCY 53 0.0009
439 URINE ODOUR ABNORMAL 5 0.0008
440 HAND FRACTURE 6 0.0008
441 PLEURISY 5 0.0008
442 MUSCULAR WEAKNESS 95 0.0008
443 SUBCUTANEOUS ABSCESS 4 0.0008
444 PRODUCT SUBSTITUTION ISSUE 48 0.0008
445 BREAST CANCER 77 0.0008
446 FOETAL EXPOSURE DURING PREGNANCY 67 0.0008
447 KIDNEY INFECTION 16 0.0008
448 MUCOUS STOOLS 4 0.0008
449 PRESCRIBED UNDERDOSE 16 0.0008
450 DRUG TOLERANCE 4 0.0008
451 THERAPEUTIC RESPONSE CHANGED 5 0.0008
452 GASTROINTESTINAL INFECTION 7 0.0008
453 INCREASED UPPER AIRWAY SECRETION 4 0.0008
454 GAIT INABILITY 26 0.0008
455 URINARY INCONTINENCE 23 0.0008
456 LIMB DISCOMFORT 24 0.0008
457 SKIN NECROSIS 4 0.0008
458 ACTINIC KERATOSIS 2 0.0008
459 PARAESTHESIA 121 0.0008
460 TONSILLITIS 4 0.0008
461 DYSGRAPHIA 5 0.0008
462 LIVER FUNCTION TEST ABNORMAL 22 0.0008
463 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
464 PREMATURE DELIVERY 12 0.0008
465 BLOOD PRESSURE FLUCTUATION 18 0.0007
466 MENINGITIS 5 0.0007
467 THYROID CANCER 9 0.0007
468 HEPATIC ENZYME INCREASED 50 0.0007
469 NONSPECIFIC REACTION 4 0.0007
470 DISEASE PROGRESSION 86 0.0007
471 HEMIPLEGIA 6 0.0007
472 HEPATOTOXICITY 16 0.0007
473 HEART RATE DECREASED 25 0.0007
474 HEART RATE IRREGULAR 16 0.0007
475 TONGUE DISCOMFORT 3 0.0007
476 CHOLECYSTITIS ACUTE 4 0.0007
477 VISUAL IMPAIRMENT 87 0.0007
478 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
479 HERPES VIRUS INFECTION 4 0.0007
480 HEPATIC LESION 3 0.0007
481 DRUG INTOLERANCE 67 0.0007
482 MYELODYSPLASTIC SYNDROME 10 0.0007
483 HYPOKINESIA 10 0.0007
484 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
485 ONYCHOMYCOSIS 3 0.0007
486 IMMUNE SYSTEM DISORDER 9 0.0007
487 LYMPHADENOPATHY 24 0.0007
488 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
489 MENINGITIS ASEPTIC 3 0.0007
490 ANAL INCONTINENCE 6 0.0007
491 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
492 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
493 WHITE BLOOD CELL COUNT DECREASED 72 0.0007
494 HEPATITIS B 4 0.0007
495 HAEMOGLOBIN INCREASED 3 0.0007
496 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
497 ATRIOVENTRICULAR BLOCK 5 0.0006
498 BLEPHAROSPASM 4 0.0006
499 TREATMENT FAILURE 52 0.0006
500 THERAPY NON-RESPONDER 28 0.0006
501 RHINITIS 5 0.0006
502 MITRAL VALVE INCOMPETENCE 7 0.0006
503 ENCEPHALOPATHY 15 0.0006
504 POLYURIA 5 0.0006
505 METASTASES TO BONE 10 0.0006
506 STAPHYLOCOCCAL SEPSIS 3 0.0006
507 WALKING AID USER 4 0.0006
508 SARS-COV-2 TEST POSITIVE 8 0.0006
509 LIVER FUNCTION TEST INCREASED 13 0.0006
510 PULMONARY MASS 9 0.0006
511 EYE PAIN 34 0.0006
512 HYPOAESTHESIA ORAL 9 0.0006
513 METASTASES TO LYMPH NODES 4 0.0006
514 URINARY TRACT INFECTION 101 0.0006
515 CARDIOVASCULAR DISORDER 15 0.0006
516 DYSLIPIDAEMIA 3 0.0006
517 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
518 MUSCULOSKELETAL CHEST PAIN 9 0.0006
519 HEPATITIS C 7 0.0006
520 EJECTION FRACTION DECREASED 9 0.0006
521 AUTOIMMUNE HEPATITIS 4 0.0006
522 PETECHIAE 6 0.0006
523 DRUG-INDUCED LIVER INJURY 18 0.0006
524 EXTRASYSTOLES 4 0.0006
525 AMENORRHOEA 10 0.0006
526 SKIN REACTION 8 0.0006
527 HEAD DISCOMFORT 10 0.0006
528 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
529 VERTIGO 34 0.0006
530 GINGIVITIS 3 0.0006
531 HAEMATURIA 19 0.0006
532 PARAESTHESIA ORAL 8 0.0006
533 ABORTION SPONTANEOUS 22 0.0005
534 GASTROENTERITIS 8 0.0005
535 NERVOUS SYSTEM DISORDER 17 0.0005
536 PROSTATIC DISORDER 3 0.0005
537 VISION BLURRED 74 0.0005
538 NEURALGIA 13 0.0005
539 FLANK PAIN 5 0.0005
540 SPINAL DISORDER 5 0.0005
541 PRODUCT AVAILABILITY ISSUE 12 0.0005
542 EXERCISE TOLERANCE DECREASED 3 0.0005
543 ENTEROCOLITIS 3 0.0005
544 LIVER DISORDER 23 0.0005
545 CONGENITAL ANOMALY 4 0.0005
546 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
547 VITAMIN D DEFICIENCY 5 0.0005
548 ASCITES 15 0.0005
549 VITREOUS FLOATERS 5 0.0005
550 BRADYKINESIA 3 0.0005
551 HEPATITIS 13 0.0005
552 POLLAKIURIA 21 0.0005
553 PREMATURE BABY 15 0.0005
554 LEUKOCYTOSIS 9 0.0005
555 NEOPLASM MALIGNANT 33 0.0005
556 MENISCUS INJURY 3 0.0005
557 INFLUENZA LIKE ILLNESS 40 0.0005
558 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
559 PAIN OF SKIN 13 0.0005
560 VISUAL ACUITY REDUCED 16 0.0005
561 CYTOMEGALOVIRUS INFECTION 8 0.0005
562 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
563 BRAIN OEDEMA 6 0.0005
564 PHOTOPSIA 3 0.0005
565 SKIN PLAQUE 4 0.0005
566 MATERNAL EXPOSURE DURING PREGNANCY 42 0.0005
567 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
568 ABSCESS LIMB 2 0.0005
569 MOVEMENT DISORDER 15 0.0005
570 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
571 CONFUSIONAL STATE 75 0.0005
572 DISTURBANCE IN ATTENTION 25 0.0005
573 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
574 ORAL HERPES 9 0.0005
575 THYROID DISORDER 7 0.0005
576 ADVERSE REACTION 6 0.0005
577 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
578 FUNGAL INFECTION 15 0.0004
579 FACIAL PAIN 4 0.0004
580 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
581 DYSSTASIA 13 0.0004
582 CHROMATURIA 10 0.0004
583 INFARCTION 3 0.0004
584 MEMORY IMPAIRMENT 60 0.0004
585 ONYCHOCLASIS 3 0.0004
586 BRAIN NEOPLASM 4 0.0004
587 HAIR GROWTH ABNORMAL 3 0.0004
588 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
589 HYPERTENSION 91 0.0004
590 MASS 6 0.0004
591 WITHDRAWAL SYNDROME 18 0.0004
592 IMPAIRED HEALING 14 0.0004
593 PHOTOPHOBIA 8 0.0004
594 RESPIRATORY TRACT INFECTION 11 0.0004
595 RETINAL HAEMORRHAGE 3 0.0004
596 HAEMATOTOXICITY 4 0.0004
597 SPEECH DISORDER 22 0.0004
598 PRODUCT PRESCRIBING ERROR 10 0.0004
599 FEELING JITTERY 8 0.0004
600 DEPRESSED MOOD 22 0.0004
601 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
602 HYPERTHYROIDISM 6 0.0004
603 CONDITION AGGRAVATED 126 0.0004
604 NOCTURIA 5 0.0004
605 UTERINE LEIOMYOMA 3 0.0004
606 HYPOPHOSPHATAEMIA 3 0.0004
607 CYST 5 0.0004
608 INJECTION SITE DISCOLOURATION 5 0.0004
609 FATIGUE 311 0.0004
610 EYE DISORDER 13 0.0004
611 EXTRA DOSE ADMINISTERED 16 0.0004
612 SUBARACHNOID HAEMORRHAGE 4 0.0004
613 EPILEPSY 12 0.0004
614 MOBILITY DECREASED 28 0.0004
615 INFLUENZA 43 0.0004
616 VENTRICULAR EXTRASYSTOLES 4 0.0004
617 PANIC ATTACK 14 0.0004
618 PLATELET COUNT INCREASED 5 0.0004
619 PALPITATIONS 44 0.0004
620 BODY HEIGHT DECREASED 4 0.0004
621 FRUSTRATION TOLERANCE DECREASED 3 0.0004
622 MUSCLE DISORDER 3 0.0004
623 FOOT FRACTURE 7 0.0004
624 UVEITIS 5 0.0004
625 GASTROINTESTINAL DISORDER 33 0.0004
626 GINGIVAL BLEEDING 5 0.0004
627 LUNG NEOPLASM MALIGNANT 15 0.0004
628 TRANSAMINASES INCREASED 8 0.0004
629 HYPERTENSIVE CRISIS 4 0.0004
630 FEELING COLD 10 0.0004
631 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
632 APHONIA 5 0.0004
633 C-REACTIVE PROTEIN INCREASED 13 0.0004
634 SKIN INFECTION 4 0.0004
635 PYREXIA 123 0.0004
636 EYE INFECTION 4 0.0004
637 HEADACHE 222 0.0004
638 SEASONAL ALLERGY 5 0.0004
639 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
640 BACK PAIN 82 0.0004
641 BLOOD PRESSURE ABNORMAL 7 0.0004
642 VITAMIN D DECREASED 3 0.0004
643 SCAB 4 0.0004
644 CHILLS 41 0.0003
645 SKIN HYPERPIGMENTATION 3 0.0003
646 FALL 116 0.0003
647 MENTAL DISORDER 15 0.0003
648 SPINAL OSTEOARTHRITIS 3 0.0003
649 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
650 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
651 BACTERAEMIA 4 0.0003
652 DIZZINESS 168 0.0003
653 MUSCLE RIGIDITY 4 0.0003
654 JAUNDICE 9 0.0003
655 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
656 MENTAL IMPAIRMENT 8 0.0003
657 INFLAMMATION 17 0.0003
658 RETCHING 7 0.0003
659 PNEUMONIA BACTERIAL 3 0.0003
660 TREMOR 54 0.0003
661 NERVE COMPRESSION 3 0.0003
662 DEVICE RELATED INFECTION 5 0.0003
663 RENAL DISORDER 15 0.0003
664 DYSKINESIA 13 0.0003
665 BRAIN FOG 5 0.0003
666 HALLUCINATION, AUDITORY 5 0.0003
667 ANGINA PECTORIS 9 0.0003
668 AFFECT LABILITY 3 0.0003
669 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
670 DIZZINESS POSTURAL 3 0.0003
671 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
672 CHOKING 6 0.0003
673 INFLAMMATORY BOWEL DISEASE 3 0.0003
674 INFECTION 44 0.0003
675 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
676 HYPOTONIA 3 0.0003
677 BRAIN INJURY 3 0.0003
678 NASOPHARYNGITIS 55 0.0003
679 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
680 BLINDNESS 12 0.0003
681 NEUTROPHIL COUNT DECREASED 12 0.0003
682 SLUGGISHNESS 3 0.0003
683 THERAPY CESSATION 15 0.0003
684 NIGHTMARE 10 0.0003
685 RESPIRATORY FAILURE 21 0.0003
686 ASTHENIA 108 0.0003
687 ECZEMA 15 0.0003
688 PANCYTOPENIA 16 0.0003
689 NECK PAIN 16 0.0003
690 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
691 COLD SWEAT 5 0.0003
692 FULL BLOOD COUNT ABNORMAL 3 0.0003
693 BLINDNESS UNILATERAL 4 0.0003
694 CHEST DISCOMFORT 29 0.0003
695 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
696 HYPOKALAEMIA 13 0.0003
697 BREAST PAIN 3 0.0003
698 JOINT INJURY 6 0.0003
699 IMPAIRED WORK ABILITY 6 0.0003
700 AGEUSIA 7 0.0003
701 INTENTIONAL DOSE OMISSION 8 0.0003
702 ISCHAEMIC STROKE 5 0.0003
703 CELLULITIS 14 0.0003
704 DISORIENTATION 11 0.0003
705 SYNOVITIS 5 0.0003
706 SEIZURE 32 0.0003
707 CHEST PAIN 51 0.0003
708 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
709 CHOLELITHIASIS 9 0.0003
710 APATHY 4 0.0003
711 MUSCULOSKELETAL STIFFNESS 24 0.0003
712 WOUND INFECTION 3 0.0003
713 DRUG WITHDRAWAL SYNDROME 24 0.0003
714 COLON CANCER 4 0.0003
715 PAIN IN EXTREMITY 79 0.0003
716 ABDOMINAL PAIN 62 0.0003
717 PANCREATITIS 14 0.0003
718 HYPERHIDROSIS 34 0.0003
719 DYSPHAGIA 25 0.0003
720 BREAST CANCER FEMALE 7 0.0003
721 MIGRAINE 25 0.0003
722 AMNESIA 17 0.0003
723 LOWER LIMB FRACTURE 5 0.0003
724 GLAUCOMA 5 0.0003
725 OROPHARYNGEAL PAIN 24 0.0003
726 FREQUENT BOWEL MOVEMENTS 7 0.0003
727 TACHYCARDIA 23 0.0003
728 TENDONITIS 4 0.0003
729 SOMNOLENCE 52 0.0003
730 EYELID OEDEMA 3 0.0003
731 MALAISE 113 0.0003
732 EAR PAIN 5 0.0003
733 BURNING SENSATION 18 0.0003
734 THERAPY PARTIAL RESPONDER 4 0.0003
735 SPINAL PAIN 3 0.0003
736 MENORRHAGIA 5 0.0003
737 ARRHYTHMIA 12 0.0003
738 DISABILITY 5 0.0003
739 MENTAL STATUS CHANGES 7 0.0003
740 CHOLECYSTITIS 3 0.0003
741 SPINAL FRACTURE 5 0.0002
742 HIP FRACTURE 8 0.0002
743 BLOOD POTASSIUM INCREASED 4 0.0002
744 CYTOPENIA 3 0.0002
745 ADVERSE DRUG REACTION 22 0.0002
746 PRODUCT DOSE OMISSION ISSUE 72 0.0002
747 FEELING HOT 15 0.0002
748 HYPERCALCAEMIA 3 0.0002
749 ILLNESS 25 0.0002
750 PANCREATIC CARCINOMA 7 0.0002
751 HEART RATE INCREASED 24 0.0002
752 PHARYNGITIS 3 0.0002
753 ACUTE CORONARY SYNDROME 2 0.0002
754 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
755 PSYCHOTIC DISORDER 7 0.0002
756 CANDIDA INFECTION 4 0.0002
757 ATRIAL FIBRILLATION 23 0.0002
758 NEUTROPENIA 32 0.0002
759 HEPATIC CYTOLYSIS 3 0.0002
760 HAEMATOMA 6 0.0002
761 HYPONATRAEMIA 13 0.0002
762 PRODUCT DISPENSING ERROR 5 0.0002
763 FEELING ABNORMAL 55 0.0002
764 BLOOD PRESSURE INCREASED 35 0.0002
765 EOSINOPHILIA 4 0.0002
766 GASTRITIS 6 0.0002
767 HOT FLUSH 17 0.0002
768 EYE HAEMORRHAGE 3 0.0002
769 COUGH 63 0.0002
770 SINUSITIS 23 0.0002
771 CEREBRAL HAEMORRHAGE 8 0.0002
772 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
773 HEAD INJURY 7 0.0002
774 ABDOMINAL DISCOMFORT 37 0.0002
775 ALOPECIA 43 0.0002
776 ACCIDENTAL OVERDOSE 8 0.0002
777 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
778 CATARACT 13 0.0002
779 MUSCLE TWITCHING 5 0.0002
780 DIVERTICULITIS 6 0.0002
781 HEPATIC STEATOSIS 4 0.0002
782 BLOOD CHOLESTEROL INCREASED 10 0.0002
783 BACTERIAL INFECTION 4 0.0002
784 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
785 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
786 OSTEONECROSIS 7 0.0002
787 ABORTION INDUCED 2 0.0002
788 DRUG INEFFECTIVE 279 0.0002
789 ACNE 16 0.0002
790 BLOOD PRESSURE DECREASED 14 0.0002
791 HYPERSOMNIA 6 0.0002
792 IMPAIRED QUALITY OF LIFE 3 0.0002
793 PAIN 128 0.0002
794 CHOLESTASIS 4 0.0002
795 CONTUSION 20 0.0002
796 ANOSMIA 3 0.0002
797 MUSCLE SPASMS 38 0.0002
798 MYOCARDIAL INFARCTION 36 0.0002
799 DYSPHONIA 12 0.0002
800 AGITATION 15 0.0002
801 ACUTE MYOCARDIAL INFARCTION 6 0.0002
802 LABORATORY TEST ABNORMAL 6 0.0002
803 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
804 HAEMATOCRIT DECREASED 4 0.0002
805 RHINORRHOEA 13 0.0002
806 TREATMENT NONCOMPLIANCE 11 0.0002
807 THROAT IRRITATION 9 0.0002
808 CYTOKINE RELEASE SYNDROME 4 0.0002
809 HYPOTENSION 40 0.0002
810 PRODUCT PHYSICAL ISSUE 4 0.0002
811 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
812 MEDICATION ERROR 11 0.0002
813 INSURANCE ISSUE 3 0.0002
814 THERAPY INTERRUPTED 14 0.0002
815 TINNITUS 9 0.0002
816 RIB FRACTURE 4 0.0002
817 PNEUMONIA 62 0.0002
818 NERVOUSNESS 10 0.0002
819 MOUTH ULCERATION 4 0.0002
820 DECREASED APPETITE 44 0.0002
821 PNEUMOTHORAX 3 0.0002
822 OBESITY 3 0.0002
823 MOOD SWINGS 6 0.0002
824 SCIATICA 3 0.0002
825 ABSCESS 3 0.0002
826 HYPOTHYROIDISM 6 0.0002
827 HEPATIC FUNCTION ABNORMAL 7 0.0002
828 OFF LABEL USE 164 0.0002
829 BLADDER CANCER 11 0.0002
830 BLOOD BILIRUBIN INCREASED 5 0.0002
831 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
832 DISCOMFORT 11 0.0002
833 SKIN DISORDER 6 0.0002
834 TOOTH DISORDER 4 0.0002
835 SEPSIS 20 0.0002
836 WEIGHT INCREASED 40 0.0002
837 BRONCHITIS 13 0.0002
838 INJECTION SITE REACTION 12 0.0002
839 SKIN DISCOLOURATION 8 0.0002
840 DYSPEPSIA 17 0.0002
841 INSOMNIA 46 0.0002
842 ORTHOSTATIC HYPOTENSION 3 0.0002
843 INTENTIONAL PRODUCT MISUSE 15 0.0002
844 METASTASES TO LIVER 3 0.0002
845 THIRST 3 0.0002
846 ACCIDENT 2 0.0002
847 ROAD TRAFFIC ACCIDENT 7 0.0002
848 DEPRESSION 38 0.0002
849 INFUSION RELATED REACTION 11 0.0002
850 TOOTHACHE 3 0.0002
851 LACRIMATION INCREASED 5 0.0002
852 THERAPEUTIC RESPONSE DECREASED 10 0.0002
853 ILL-DEFINED DISORDER 10 0.0002
854 LIVER INJURY 4 0.0002
855 EMOTIONAL DISORDER 5 0.0002
856 DYSPNOEA EXERTIONAL 6 0.0002
857 FRACTURE 3 0.0002
858 ABDOMINAL PAIN LOWER 4 0.0002
859 PROTEINURIA 3 0.0002
860 LOSS OF CONSCIOUSNESS 20 0.0002
861 CONSTIPATION 34 0.0002
862 PRESCRIBED OVERDOSE 3 0.0002
863 UNRESPONSIVE TO STIMULI 4 0.0002
864 NAUSEA 121 0.0002
865 MUCOSAL INFLAMMATION 4 0.0002
866 NEPHROLITHIASIS 7 0.0002
867 EAR INFECTION 4 0.0002
868 TYPE 2 DIABETES MELLITUS 5 0.0001
869 PLEURAL EFFUSION 9 0.0001
870 TASTE DISORDER 3 0.0001
871 ANGER 5 0.0001
872 LIMB INJURY 4 0.0001
873 MYALGIA 25 0.0001
874 PALLOR 4 0.0001
875 WEIGHT DECREASED 41 0.0001
876 VOMITING 69 0.0001
877 MOOD ALTERED 4 0.0001
878 ACUTE HEPATIC FAILURE 2 0.0001
879 HYPERSENSITIVITY 27 0.0001
880 PERITONITIS 3 0.0001
881 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
882 RENAL FAILURE 19 0.0001
883 HYPERKALAEMIA 5 0.0001
884 CEREBROVASCULAR ACCIDENT 24 0.0001
885 ANXIETY 40 0.0001
886 SYNCOPE 14 0.0001
887 CONVULSION 8 0.0001
888 CARDIAC DISORDER 13 0.0001
889 SWELLING 13 0.0001
890 CRYING 5 0.0001
891 NASAL CONGESTION 8 0.0001
892 DYSPNOEA 77 0.0001
893 ABDOMINAL DISTENSION 14 0.0001
894 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
895 STOMATITIS 8 0.0001
896 FLUSHING 13 0.0001
897 PRODUCTIVE COUGH 6 0.0001
898 RASH ERYTHEMATOUS 6 0.0001
899 FIBROMYALGIA 3 0.0001
900 DIARRHOEA 79 0.0001
901 LETHARGY 7 0.0001
902 OSTEOPOROSIS 5 0.0001
903 CARDIAC ARREST 10 0.0001
904 FEBRILE NEUTROPENIA 8 0.0001
905 EPISTAXIS 9 0.0001
906 VIRAL INFECTION 4 0.0001
907 BONE PAIN 7 0.0001
908 EYE PRURITUS 4 0.0001
909 IRRITABILITY 7 0.0001
910 NEUROPATHY PERIPHERAL 11 0.0001
911 DELIRIUM 4 0.0001
912 ARTHRITIS 9 0.0001
913 PLATELET COUNT DECREASED 12 0.0001
914 PULMONARY OEDEMA 5 0.0001
915 PNEUMONITIS 3 0.0001
916 RESTLESSNESS 4 0.0001
917 DYSGEUSIA 8 0.0001
918 AGRANULOCYTOSIS 2 0.0001
919 URTICARIA 18 0.0001
920 WOUND 3 0.0001
921 THROMBOCYTOPENIA 12 0.0001
922 OEDEMA PERIPHERAL 13 0.0001
923 FLATULENCE 6 0.0001
924 OCULAR HYPERAEMIA 5 0.0001
925 ACUTE RESPIRATORY FAILURE 2 0.0001
926 ABDOMINAL PAIN UPPER 21 0.0001
927 ABNORMAL BEHAVIOUR 4 0.0001
928 RESPIRATORY DISORDER 3 0.0001
929 HEPATIC FAILURE 3 0.0001
930 DRY MOUTH 8 0.0001
931 PERIPHERAL SWELLING 15 0.0001
932 SWOLLEN TONGUE 3 0.0001
933 RENAL IMPAIRMENT 8 0.0001
934 PULMONARY EMBOLISM 9 0.0001
935 OSTEOARTHRITIS 4 0.0001
936 ARTHRALGIA 39 0.0001
937 RECTAL HAEMORRHAGE 4 0.0001
938 HYPOACUSIS 4 0.0001
939 OEDEMA 5 0.0001
940 PRURITUS 35 0.0001
941 STAPHYLOCOCCAL INFECTION 3 0.0001
942 THROMBOSIS 7 0.0001
943 ADVERSE EVENT 8 0.0001
944 RASH MACULAR 3 0.0001
945 SLEEP DISORDER 6 0.0001
946 PSORIASIS 11 0.0001
947 COMA 4 0.0001
948 HYPERGLYCAEMIA 3 0.0001
949 DIABETES MELLITUS 6 0.0001
950 RASH 34 0.0001
951 SWELLING FACE 5 0.0001
952 BLOOD CREATININE INCREASED 5 0.0001
953 SUICIDAL IDEATION 7 0.0001
954 MUSCULOSKELETAL PAIN 4 0.0001
955 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
956 HAEMATOCHEZIA 4 0.0001
957 ARTHROPATHY 4 0.0001
958 SKIN BURNING SENSATION 5 0.0001
959 SEPTIC SHOCK 3 0.0001
960 DEHYDRATION 9 0.0001
961 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
962 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
963 UNEVALUABLE EVENT 5 0.0001
964 SUICIDE ATTEMPT 4 0.0001
965 DEATH 55 0.0001
966 DRUG INTERACTION 10 0.0001
967 CARDIAC FAILURE 5 0.0001
968 DEEP VEIN THROMBOSIS 4 0.0001
969 DRY EYE 3 0.0001
970 AGGRESSION 3 0.0001
971 SKIN EXFOLIATION 5 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
973 ERYTHEMA 12 0.0001
974 ANAEMIA 10 0.0001
975 CARDIAC FAILURE CONGESTIVE 4 0.0000
976 EMOTIONAL DISTRESS 6 0.0000
977 INJECTION SITE PAIN 15 0.0000
978 HAEMOGLOBIN DECREASED 5 0.0000
979 PRODUCT USE ISSUE 9 0.0000
980 HAEMORRHAGE 5 0.0000
981 ASTHMA 5 0.0000
982 INJURY 3 0.0000
983 BLOOD GLUCOSE INCREASED 8 0.0000
984 HOSPITALISATION 5 0.0000
985 NO ADVERSE EVENT 5 0.0000
986 TOXICITY TO VARIOUS AGENTS 4 0.0000
987 PRODUCT QUALITY ISSUE 3 0.0000
988 INCORRECT DOSE ADMINISTERED 5 0.0000
989 ACUTE KIDNEY INJURY 2 0.0000